Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer

HIGHLIGHTS

  • who: Wanze Huang from the DepartmentSouth University have published the research work: Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer, in the Journal: Scientific Reports Scientific Reports of October/29,/2021
  • what: The authors systematically examined the relationship between the expression of prognostic costimulatory molecules and the clinical characteristics and immune microenvironment of patients with colon cancer. The findings of this study provide novel insights into the development of risk stratification and immunotherapeutic strategies. This study had a retrospective design and was based on public databases.
  • future . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?